FEATURED EDITORIAL
Biological printing (bioprinting; also called biofabrication) is a form of additive manufacturing that uses living cells, proteins, and nutrients as the basis of raw materials in pharmaceutical development.
- FDA Issues New Guidance: Nonclinical Safety Assessment Of Oligonucleotide-Based Therapeutics
- How Atsena Got Its Gene Therapy To Spread Subretinally To Treat XLRS
- 2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?
- Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research
- Should We Explore Suicidality In Animals During Preclinical Drug Development?
- How To Overcome Immune Rejection In iPSC-based Gene Therapy
- Emerging Partnership Trends In Oligo-Based Medicines
FEATURED APPLICATION CONTENT
-
The repetitive nature of routine laboratory procedures can put technicians and scientists at risk for repetitive strain injury. Routine activities often include reoccurrence of the same movements over and over, which can take a toll on hands, wrists and shoulders and ultimately can lead to serious damage. Choosing the right tools can make all the difference.
-
Learn how Pierre Fabre Laboratories streamlined their antibody development with the implementation of a new platform, enabling efficient and multi-parameter stability measurements.
-
See how Cube Biotech and MIT researchers used dynamic light scattering (DLS) and nano differential scanning fluorimetry (nanoDSF) to find the best nanodisc conditions for three membrane proteins.
-
Membrane proteins are vital for drug discovery, but traditional techniques can disrupt their structure. This study showcases a new method that maintains native conformation during analysis.
-
Discover the ability of a novel HEK293 suspension cell line for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA levels.
-
Discover strategies to overcome the challenges of nonclinical testing for pediatric and rare disease therapies, ensuring regulatory compliance and successfully advancing your medicinal products to the clinic.
-
Address unique anatomical challenges to deliver reliable, IND-enabling data for innovative therapies by relying on our expertise to design and execute your complex ocular safety study.
-
By having a tailored proactive drug development approach, companies can accelerate their API's journey through preclinical development, ensuring the creation of a stable, high-potency formulation.
-
Uncover how our team was able to address the challenges of evaluating treatments that reduce food consumption and cause body weight loss while ensuring animal health and study integrity.
-
This stem cell transplantation technique, using real-time MRI imaging and precise stereotactic guidance, ensures accurate treatment delivery in macaque models for optimal brain region targeting.
-
Discover how the Sinclair Nanopig™ is transforming preclinical research and drug safety assessment to advance the future of translational science.
-
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
FEATURED NEWS HEADLINES
- Rakovina Therapeutics Announces Additional Synthesized Compounds In Its AI-Driven Cancer Drug Discovery Program
- China Medical University And Healthcare System Pioneers AI-Driven Drug Discovery And Allogeneic CAR-T Therapy: A Groundbreaking Leap In Cancer Treatment
- FDA Accepts Integral Molecular's Membrane Proteome Array™ Qualification Plan, Advancing The Platform For Approval As A Drug Development Tool
- How Advanced Drug Discovery Tech Is Fast-Tracking New Treatments
- Astellas Submits New Drug Application For Conditional Approval Of Avacincaptad Pegol For Geographic Atrophy In Japan
- Georgia Southern Researchers Identify Promising Molecules To Target Cancer Metastasis
- Data4Cure Partners With Pfizer To Deliver New Insights With AI And Data-Driven Knowledge Graphs
- COUR Pharmaceuticals Secures FDA Clearance Of IND Application For CNP-103 In Type 1 Diabetes
- Cannovation Clinical Research Partners Announces New Divisions And Leadership To Drive Innovation In Drug Development
- Onco-Innovations Completes Acquisition Of Inka Health To Accelerate AI-Driven Cancer Research And Drug Development
ARCHIVED NEWSLETTER
- 02.04.25 -- How Atsena Got Its Gene Therapy To Spread Subretinally To Treat XLRS
- 01.29.25 -- Peptide-Based Therapeutics: Innovations In Development And Scalable Solutions
- 01.28.25 -- 2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?
- 01.21.25 -- Survey Findings: How Are IDMP Readiness Efforts Progressing?
- 01.14.25 -- Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research